Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

Rhea-AI Summary

Cannara Biotech Inc. (OTCQB: LOVFF), a vertically integrated cannabis producer with two mega facilities in Québec totaling over 1,650,000 sq. ft., has scheduled its fiscal Q3 2025 earnings release for July 28, 2025.

The financial results for the quarter ended May 31, 2025, will be released at 7:00 a.m. ET, followed by an earnings webcast at 11:00 a.m. ET. CFO Nicholas Sosiak will host the webcast, which will include prepared remarks and a Q&A session. Investors can submit questions in advance via email to investors@cannara.ca.

MONTREAL, July 21, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that it will release its financial results for the fiscal third quarter ended May 31, 2025, on Monday, July 28, 2025, at 7:00 a.m. ET.

Cannara Biotech’s CFO, Nicholas Sosiak, will host an earnings webcast on Monday, July 28, 2025 at 11 a.m. ET., consisting of prepared remarks followed by a live question-and-answer session.

Participants can register for the conference call and webcast here or on the Cannara Biotech website at https://www.cannara.ca/investors/company-events/. For interested individuals unable to join, the event will be archived on the company’s website.

Investors are encouraged to submit questions in advance to investors@cannara.ca. While live questions will be accepted during the session, priority will be given to those submitted by email.

CONTACT

Nicholas Sosiak, CPA, CA Chief Financial Officer nick@cannara.ca

Zohar Krivorot  President & Chief Executive Officer  zohar@cannara.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

ABOUT CANNARA

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of premium-grade cannabis products at disruptive prices for the Canadian market. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.

CAUTIONARY STATEMENT REGARDING “FORWARD-LOOKING” INFORMATION

This news release may contain “forward-looking information” within the meaning of Canadian securities legislation (“forward-looking statements”). These forward-looking statements are made as of the date of this MD&A and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required under applicable securities legislation. All statements other than statements of historical facts included in this document constitute forward-looking information, including but not limited to statements with respect to Cannara future performance, market growth, and business expansion.

Forward-looking statements relate to future events or future performance and reflect Company management’s expectations or beliefs regarding future events and include, but are not limited to, the Company and its operations, its projections or estimates about its future business operations, its planned expansion activities, anticipated product offerings, the adequacy of its financial resources, the ability to adhere to financial and other covenants under lending agreements, future economic performance, and the Company’s ability to become a leader in the field of cannabis cultivation, production, and sales.

In certain cases, forward-looking statements can be identified by the use of words such as “plans,” “expects” or “does not expect,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or statements that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “occur” or “be achieved” or the negative of these terms or comparable terminology. In this document, certain forward-looking statements are identified by words including “may,” “future,” “expected,” “intends” and “estimates.” By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Forward-looking information is based upon a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those that are disclosed in, or implied by, such forward-looking information. These risks and uncertainties include, but are not limited to, the risk factors which are discussed in greater detail under “Risk Factors” in the Company’s AIF available on SEDAR+ at www.sedarplus.ca and under the “Investor Area” section of our website at https://www.cannara.ca/en/investor-area.

Other risks not presently known to the Company or that the Company believes are not significant could also cause actual results to differ materially from those expressed in its forward-looking statements. Although the forward-looking information contained herein is based upon what we believe are reasonable assumptions, readers are cautioned against placing undue reliance on this information since actual results may vary from the forward-looking information. Certain assumptions were made in preparing the forward-looking information concerning the availability of capital resources, business performance, market conditions, as well as customer demand. Consequently, all of the forward-looking information contained herein is qualified by the foregoing cautionary statements, and there can be no guarantee that the results or developments that we anticipate will be realized or, even if substantially realized, that they will have the expected consequences or effects on our business, financial condition or results of operation. Unless otherwise noted or the context otherwise indicates, the forward-looking information contained herein is provided as of the date hereof, and we do not undertake to update or amend such forward-looking information whether as a result of new information, future events or otherwise, except as may be required by applicable law.

FAQ

When will Cannara Biotech (LOVFF) release its Q3 2025 earnings?

Cannara Biotech will release its Q3 2025 earnings on Monday, July 28, 2025 at 7:00 a.m. ET.

How can investors participate in Cannara Biotech's Q3 2025 earnings call?

Investors can register for the earnings webcast through Cannara's website at cannara.ca/investors/company-events/. The webcast will be held on July 28, 2025 at 11:00 a.m. ET.

What is the size of Cannara Biotech's production facilities?

Cannara Biotech operates two mega facilities in Québec spanning over 1,650,000 sq. ft. for premium-grade cannabis production.

How can investors submit questions for Cannara Biotech's Q3 2025 earnings call?

Investors can submit questions in advance by email to investors@cannara.ca. While live questions will be accepted during the session, priority will be given to emailed questions.